Viraferonpeg 150mcg Injection
Marketer
MSD Pharmaceuticals Pvt Ltd
Salt Composition
Pegylated Interferon Alpha 2B (150mcg)
Overview Viraferonpeg 150mcg Injection
Peginterferon alfa-2a 150 mcg injection treats chronic hepatitis C (HCV). Administered intravenously by a healthcare professional, treatment duration is determined by your physician based on individual response. Strict adherence to the prescribed dosage is crucial; misuse can lead to severe adverse effects. While benefits may take weeks or months to manifest, discontinue use only under medical guidance. Common side effects include headache, vertigo, sleep disturbances, emesis, and nausea. This medication can decrease blood cell counts, raising infection risk; report fever, chills, rashes, respiratory distress, unusual bleeding/bruising, or dark urine immediately. Regular blood work monitoring includes complete blood count, thyroid, liver, kidney function, and electrolytes. Prior to commencing treatment, disclose any pre-existing liver, kidney, or mental health conditions. Report any mood alterations, depression, visual disturbances, or suicidal ideation during therapy. Inform your physician of all concurrent medications due to potential interactions. This medication is contraindicated in pregnancy and lactation; reliable contraception for both partners is essential throughout treatment.
Uses of Viraferonpeg 150mcg Injection
Persistent infection with the hepatitis C virus (HCV)
Major Benefits of Viraferonpeg 150mcg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Viraferonpeg 150mcg Injection:
- Abdominal pain
- Agitation
- Anxiety
- Blurred vision
- Cough
- Decreased appetite
- Decreased white blood cell count
- Depression
- Dizziness
- Dryness in mouth
- Fatigue
- Headache
- Impaired concentration
- Indigestion
- Insomnia (difficulty in sleeping)
- Nausea
- Nervousness
- Sore throat
- Stomatitis (Inflammation of the mouth)
- Viral infection
- Vomiting
How to use Viraferonpeg 150mcg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Viraferonpeg 150mcg Injection works:
Peginterferon alfa-2a (150 mcg injection) influences the body's immune response.
SAFETY ADVICE
AlcoholCAUTION
Use of alcohol with Viraferonpeg 150mcg Injection requires careful consideration. Physician consultation is recommended.
PregnancyCONSULT YOUR DOCTOR
The use of Viraferonpeg 150mcg Injection during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the potential benefits against any risks prior to prescribing. Seek medical advice.
Breast feedingSAFE IF PRESCRIBED
Administering Viraferonpeg 150mcg Injection while breastfeeding is likely safe. Available human data indicates minimal risk to the infant.
DrivingUNSAFE
Administration of Viraferonpeg 150mcg Injection can induce adverse reactions potentially impairing driving capabilities. Drowsiness, cognitive impairment, lethargy, and tiredness are possible effects; therefore, patients should refrain from operating vehicles.
KidneyUNSAFE
Use of the injectable medication Viraferonpeg 150mcg is likely unsafe for individuals with kidney disease and should be avoided. Seek medical advice from your physician. Patients with impaired kidney function require careful monitoring when considering this treatment.
LiverCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Viraferonpeg 150mcg Injection to individuals with hepatic impairment. Physician consultation is recommended.
What if you forget to take Viraferonpeg 150mcg Injection :
Should you forget a dose of Viraferonpeg 150mcg Injection, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Viraferonpeg 150mcg Injection
| Label | Value |
|---|---|
| Chemical Type | Interferon signaling |
| Developing Habits | No. |
| Treatment Category | Cancer Medications |
| Action Class | Interferon proteins |
3,018 People bought this recently